Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Marchetti

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 2, 2003
Age-specific seroprevalence of Human Herpesvirus 8 in Mediterranean regionsP Cattani, F Cerimele, D Porta, et al.
Cancer Chemotherapy and Pharmacology|September 27, 2012
Pharmacokinetics of eribulin mesylate in patients with solid tumors and hepatic impairmentL A Devriese, P O Witteveen, S Marchetti, et al.
Journal of Biological Regulators and Homeostatic Agents|December 1, 2017
Correlation between gamma glutamyltransferase fractions and bone qualityM Franzini, A Nesti, D Panetta, et al.
The Journal of Antimicrobial Chemotherapy|October 15, 2025
Time to anti-cancer treatment resumption after SARS-CoV-2 infection in patients with active haematological diseases undergoing combined antiviral treatmentsE Matteini, C Pinnetti, F Frondizi, et al.
ESMO Open|October 2, 2024
Curative immune checkpoint inhibitors therapy in patients with mismatch repair-deficient locally advanced rectal cancer: a real-world observational studyF Tosi, L Salvatore, E Tamburini, et al.
Leukemia|November 15, 2014
GAPDH enhances the aggressiveness and the vascularization of non-Hodgkin's B lymphomas via NF-κB-dependent induction of HIF-1αJ Chiche, S Pommier, M Beneteau, et al.
Cell Death and Differentiation|June 6, 2015
NIK promotes tissue destruction independently of the alternative NF-κB pathway through TNFR1/RIP1-induced apoptosisL Boutaffala, M J M Bertrand, C Remouchamps, et al.
ESMO Open|December 4, 2022
Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnosticsL J Schipper, K G Samsom, P Snaebjornsson, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 2, 2003
Age-specific seroprevalence of Human Herpesvirus 8 in Mediterranean regionsP Cattani, F Cerimele, D Porta, et al.
Cancer Chemotherapy and Pharmacology|September 27, 2012
Pharmacokinetics of eribulin mesylate in patients with solid tumors and hepatic impairmentL A Devriese, P O Witteveen, S Marchetti, et al.
Journal of Biological Regulators and Homeostatic Agents|December 1, 2017
Correlation between gamma glutamyltransferase fractions and bone qualityM Franzini, A Nesti, D Panetta, et al.
The Journal of Antimicrobial Chemotherapy|October 15, 2025
Time to anti-cancer treatment resumption after SARS-CoV-2 infection in patients with active haematological diseases undergoing combined antiviral treatmentsE Matteini, C Pinnetti, F Frondizi, et al.
ESMO Open|October 2, 2024
Curative immune checkpoint inhibitors therapy in patients with mismatch repair-deficient locally advanced rectal cancer: a real-world observational studyF Tosi, L Salvatore, E Tamburini, et al.
Leukemia|November 15, 2014
GAPDH enhances the aggressiveness and the vascularization of non-Hodgkin's B lymphomas via NF-κB-dependent induction of HIF-1αJ Chiche, S Pommier, M Beneteau, et al.
Cell Death and Differentiation|June 6, 2015
NIK promotes tissue destruction independently of the alternative NF-κB pathway through TNFR1/RIP1-induced apoptosisL Boutaffala, M J M Bertrand, C Remouchamps, et al.
ESMO Open|December 4, 2022
Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnosticsL J Schipper, K G Samsom, P Snaebjornsson, et al.
Pageof 8